Internal Medicine Doctors in Edwardsville, PA Accepting Medicare
5 Internal Medicine doctors found. Showing 1 - 5
 Dr. Aman Ali, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 490 Northampton St, Suite 1, Edwardsville, PA 18704 Phone: 570-288-8100 Fax: 570-288-7987 |
Charles Joseph Scrobola, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 75 South Wyoming Avenue Suite 2, Edwardsville, PA 18704 Phone: 570-824-2800 Fax: 570-718-1481 |
Martin B Fried, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 490 Northampton St, Gateway Suite 1, Edwardsville, PA 18704 Phone: 570-288-8100 Fax: 570-288-7987 |
Dr. Mohammad Khaled Tashkandi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 490 Northampton St Ste 1, Edwardsville, PA 18704 Phone: 570-288-8100 Fax: 570-288-8100 |
Dr. Thomas J Castellano, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 490 Northampton St, Gateway Suite 1, Edwardsville, PA 18704 Phone: 570-288-8100 Fax: 570-288-7987 |
News Archive
Using machine learning on ultrasound images to predict risk of thyroid cancer
Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of thyroid nodules are not cancerous and cause no symptoms.
EHOB announces release of Position Perfect System
EHOB, Inc., a leading provider of affordable products effective in the prevention and treatment of pressure ulcers, is announcing today the release of the Position Perfect System. Designed as a unique turning, transferring and positioning system, it not only complies with facility turning protocols but also protects patients from added pressure and shearing forces.
XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma
On May 29, 2011 XTL has announced that its rHuEPO drug which is currently in preparations for phase 2 clinical trial, has been granted an Orphan-drug designation by the US Food and Drug Administration (FDA) for treatment of Multiple Myeloma blood cancer.
Addition of sorafenib to chemotherapy does not prolong survival
The addition of sorafenib to gemcitabine/cisplatin fails to provide any additional benefit in chemotherapy-naïve patients with nonsquamous non-small-cell lung cancer, research shows.
› Verified 5 days ago
Internal Medicine
Gastroenterology
Family Medicine
General Practice
Pain Medicine